Global Urinary Incontinence Treatment Devices Market To Expand Massively As Contura Receives The U.S. FDA Clearance For Injectable Hydrogel To Treat SUI In Women
Urinary Incontinence is a very common medical condition that affects millions of men and women. Urinary Incontinence can cause tremendous embarrassment to the person who suffers from it. It requires a great deal of patience and understanding from sufferers, but there is hope. Urinary Incontinence Treatment Devices includes a wide range of medical products designed to control or prevent the involuntary loss of urine. Urinary Incontinence Treatments Devices has come a long way since their inception and is now available in a variety of applications and forms. Urinary incontinence has many underlying causes. The most common is aging, although stress, surgery, disease, and obesity can all contribute to an elderly person developing incontinence. Urinary incontinence can also be caused by using certain drugs, and/or sexually transmitted diseases.
Increasing prevalence of urinary
incontinence is expected to drive growth of the global urinary incontinence treatment devices market during the forecast period. According to the Official
Foundation of the American Urological Association, around a quarter to third of
women and men in the U.S. suffer from urinary incontinence. According to the
same source, around 33 million have overactive bladder, with symptoms such as
frequency and urgency. According to the World Health Organization (WHO), in
2017, the prevalence of urinary incontinence ranges from 9.9% to 36.1%
globally. As a result of this, the demand for urinary incontinence treatment
devices has increased. Thus, these factors are expected to drive growth of the
global urinary incontinence treatment devices market during the forecast
period. Furthermore, rising geriatric population is expected to boost the
global urinary incontinence treatment devices market growth over the forecast
period.
However, lack of awareness regarding
the benefits of these devices and the risk associated with the procedures is
expected to hamper the global urinary incontinence treatment devices market
growth over the forecast period. Among regions, North America is expected to
witness significant growth in the global urinary incontinence treatment devices
market during the forecast period. This is owing to the presence of a massive
patient pool and growing geriatric population in the region. Furthermore, Asia
Pacific is expected to register a robust growth rate over the forecast period,
owing to the high population base and increasing disposable income across the
region. Besides, rising patient awareness in emerging economies such as India,
Japan, and China are expected to propel the regional market growth in the near
future.
Key players operating in the global
urinary incontinence treatment devices market are Boston Scientific
Corporation, Hollister Incorporated, Becton, Dickinson and Company, Teleflex
Incorporated, Coloplast Corp, Contura, Medtronic plc, Promedon Group, ZSI
Surgical Implants S.R.L., A.M.I. GmbH, and Johnson & Johnson.
For instance, in February 2020,
Contura received the U.S. Food and Drug Administration (FDA) approval for an
injectable hydrogel to treat stress urinary incontinence (SUI) in women.
Comments
Post a Comment